EMA Authorised: Macitentan AccordPharma (macitentan) — Accord Healthcare

View source ↗

Summary

The EMA authorised Macitentan AccordPharma (macitentan) for the treatment of pulmonary hypertension, including pulmonary arterial hypertension. Accord Healthcar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Pulmonary Hypertension

Drugs mentioned

• Macitentan AccordPharma (macitentan)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Accord Healthcare. Decision date: 24/09/2025